Smith & Nephew plc (SNN)

NYSE: SNN · IEX Real-Time Price · USD
26.42
-0.09 (-0.34%)
Mar 1, 2024, 4:00 PM EST - Market closed
-0.34%
Market Cap 11.55B
Revenue (ttm) 5.55B
Net Income (ttm) 263.00M
Shares Out 435.56M
EPS (ttm) 0.60
PE Ratio 44.03
Forward PE 14.37
Dividend $0.75 (2.84%)
Ex-Dividend Date Oct 5, 2023
Volume 945,589
Open 26.38
Previous Close 26.51
Day's Range 26.15 - 26.58
52-Week Range 21.53 - 33.09
Beta 0.52
Analysts Buy
Price Target 33.00 (+24.91%)
Earnings Date Feb 27, 2024

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedur... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 16, 1999
Employees 19,094
Stock Exchange NYSE
Ticker Symbol SNN
Full Company Profile

Financial Performance

In 2023, Smith & Nephew's revenue was $5.55 billion, an increase of 6.40% compared to the previous year's $5.22 billion. Earnings were $263.00 million, an increase of 17.94%.

Financial Statements

Analyst Forecast

According to one analyst, the rating for SNN stock is "Buy" and the 12-month stock price forecast is $33.0.

Price Target
$33.0
(24.91% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use wit...

19 days ago - GlobeNewsWire

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* fo...

20 days ago - GlobeNewsWire

Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting

12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REGENET...

20 days ago - GlobeNewsWire

Australia's approach to musculoskeletal injury care and reimbursement demands rethink: Report

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and ...

7 weeks ago - GlobeNewsWire

New study confirms Smith+Nephew's REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears

7 weeks ago - GlobeNewsWire

Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

LONDON , Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased ...

5 months ago - PRNewsWire

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but...

9 months ago - MarketBeat

Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement

LONDON , June 12, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food and Drug Adm...

9 months ago - PRNewsWire

Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform

LONDON , May 16, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digita...

10 months ago - PRNewsWire

Smith+Nephew receives Innovative Technology contract from Vizient for PICO™ Single Use Negative Pressure Wound Therapy Systems

Contract awarded for products that bring improvement to healthcare industry LONDON , May 2, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announc...

10 months ago - PRNewsWire

Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty

LONDON , April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets surg...

11 months ago - PRNewsWire

3 Healthcare Dividend Payers With Big Price Growth

You don't see financial TV channels dedicated to minute-by-minute coverage of dividend yield or increases, but for investors in companies like Sanofi (NASDAQ: SNY), AstraZeneca plc (NASDAQ: AZN), and ...

Other symbols: AZNSNY
11 months ago - MarketBeat

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

LONDON , March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsu...

1 year ago - PRNewsWire

Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting

LONDON , March 8, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its latest Sports Medicine procedural innovations for j...

1 year ago - PRNewsWire

Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting

An uncompromising commitment to freedom of movement LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today unveils "Precision in Motion"...

1 year ago - PRNewsWire

Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction

LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists of the n...

1 year ago - PRNewsWire

Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation

LONDON , March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Patient...

1 year ago - PRNewsWire

Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System

Designation recognizes Vizient-contracted products that bring improvements to healthcare industry LONDON , Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology ...

1 year ago - PRNewsWire

Smith & Nephew Is Reverting to Fair Value

The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging...

1 year ago - GuruFocus

Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution

LONDON , Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hyb...

1 year ago - PRNewsWire

Smith+Nephew first to market with revision knee indication on robotics platform

LONDON , Sept. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgic...

1 year ago - PRNewsWire

Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies

LONDON , Sept. 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education curriculum through a ...

1 year ago - PRNewsWire

New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months

LONDON , Sept. 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE: SNN), the global medical technology company, today announces promising new data furthering a number of published studies supporting ...

1 year ago - PRNewsWire

Smith & Nephew: A Medical Equipment Opportunity

FTSE 100 constituent and medical equipment maker Smith & Nephew PLC ( SNN , Financial) ( LSE:SN. , Financial) seemed to be making progress after its 2021 results in February.

1 year ago - GuruFocus

Smith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend

LONDON , Aug. 4, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces that the OXINIUM Technology Tour of Change mobile exhibit will make a s...

1 year ago - PRNewsWire